A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment.
Carreau C, Lenglet T, Mosnier I, Lahlou G, Fargeot G, Weiss N, Demeret S, Salachas F, Veauville-Merllié A, Acquaviva C, Nadjar Y.
Carreau C, et al. Among authors: nadjar y.
Ann Clin Transl Neurol. 2020 Feb;7(2):250-253. doi: 10.1002/acn3.50977. Epub 2020 Feb 5.
Ann Clin Transl Neurol. 2020.
PMID: 32022482
Free PMC article.